ACIU
Price
$2.70
Change
+$0.03 (+1.12%)
Updated
Dec 31 closing price
82 days until earnings call
CRSP
Price
$39.36
Change
+$0.71 (+1.84%)
Updated
Dec 31 closing price
47 days until earnings call
Ad is loading...

ACIU vs CRSP

Header iconACIU vs CRSP Comparison
Open Charts ACIU vs CRSPBanner chart's image
AC Immune SA
Price$2.70
Change+$0.03 (+1.12%)
Volume$96.92K
CapitalizationN/A
CRISPR Therapeutics AG
Price$39.36
Change+$0.71 (+1.84%)
Volume$1.66M
CapitalizationN/A
ACIU vs CRSP Comparison Chart
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. CRSP commentary
Jan 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and CRSP is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 02, 2025
Stock price -- (ACIU: $2.70 vs. CRSP: $39.36)
Brand notoriety: ACIU and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 71% vs. CRSP: 89%
Market capitalization -- ACIU: $267.15M vs. CRSP: $3.36B
ACIU [@Biotechnology] is valued at $267.15M. CRSP’s [@Biotechnology] market capitalization is $3.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $386.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.42B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACIU and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • ACIU’s TA Score: 4 bullish, 6 bearish.
  • CRSP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ACIU and CRSP are a bad buy in the short-term.

Price Growth

ACIU (@Biotechnology) experienced а +0.75% price change this week, while CRSP (@Biotechnology) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was -3.95%, and the average quarterly price growth was +5.84%.

Reported Earning Dates

ACIU is expected to report earnings on Mar 25, 2025.

CRSP is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.36B) has a higher market cap than ACIU($267M). ACIU (0.000) and CRSP (0.000) have similar YTD gains . ACIU has higher annual earnings (EBITDA): -37.55M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. ACIU (158M). ACIU has less debt than CRSP: ACIU (3.08M) vs CRSP (228M). CRSP has higher revenues than ACIU: CRSP (200M) vs ACIU (41M).
ACIUCRSPACIU / CRSP
Capitalization267M3.36B8%
EBITDA-37.55M-313.08M12%
Gain YTD0.0000.000-
P/E RatioN/AN/A-
Revenue41M200M21%
Total Cash158M1.94B8%
Total Debt3.08M228M1%
FUNDAMENTALS RATINGS
ACIU vs CRSP: Fundamental Ratings
ACIU
CRSP
OUTLOOK RATING
1..100
661
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
8987
P/E GROWTH RATING
1..100
8882
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (53) in the Pharmaceuticals Major industry is in the same range as CRSP (61) in the Biotechnology industry. This means that ACIU’s stock grew similarly to CRSP’s over the last 12 months.

ACIU's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CRSP (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (93) in the Biotechnology industry is in the same range as ACIU (96) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to ACIU’s over the last 12 months.

CRSP's Price Growth Rating (87) in the Biotechnology industry is in the same range as ACIU (89) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to ACIU’s over the last 12 months.

CRSP's P/E Growth Rating (82) in the Biotechnology industry is in the same range as ACIU (88) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to ACIU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUCRSP
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHEIX18.65N/A
N/A
JHancock Equity Income A
FMSHX24.91N/A
N/A
Franklin Mutual Shares R6
STSNX38.25N/A
N/A
Sterling Capital SmCp Val A
GEBRX9.78N/A
N/A
Goldman Sachs ESG Em Mkts Eq R
USRTX30.28N/A
N/A
Horizon Multi-Factor U.S. Equity Advisor

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with BDTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
N/A
BDTX - ACIU
54%
Loosely correlated
N/A
VKTX - ACIU
31%
Poorly correlated
N/A
PSTX - ACIU
30%
Poorly correlated
N/A
BPMC - ACIU
30%
Poorly correlated
N/A
FGEN - ACIU
30%
Poorly correlated
N/A
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
N/A
BEAM - CRSP
73%
Closely correlated
N/A
PRME - CRSP
62%
Loosely correlated
N/A
NTLA - CRSP
61%
Loosely correlated
N/A
RXRX - CRSP
60%
Loosely correlated
N/A
EDIT - CRSP
59%
Loosely correlated
N/A
More